Braakman et al., 1991 - Google Patents
Expression of CD45 isoforms by fresh and activated human γδ T lymphocytes and natural killer cellsBraakman et al., 1991
- Document ID
- 17864341036541764999
- Author
- Braakman E
- Sturm E
- Vijverberg K
- van Krimpen B
- Gratama J
- Bolhuis R
- Publication year
- Publication venue
- International immunology
External Links
Snippet
Naive and primed αβ T cells can be distinguished on the basis of their differential expression of CD45RA and CD45RO, respectively. The present study indicates that these CD45- isoforms also identify naive and primed maturational stages of γδ T cells and natural killer …
- 210000001744 T-Lymphocytes 0 title abstract description 88
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Phillips et al. | In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy. | |
Galy et al. | Precursors of CD3+ CD4+ CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. | |
Meuer et al. | T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation. | |
Barcena et al. | Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T-and myeloid-cell development | |
Wright et al. | Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. | |
d'Angeac et al. | CD57+ T lymphocytes are derived from CD57− precursors by differentiation occurring in late immune responses | |
US20090208471A1 (en) | Isolation and Use of Human Regulatory T Cells | |
Braakman et al. | Expression of CD45 isoforms by fresh and activated human γδ T lymphocytes and natural killer cells | |
Spits et al. | Functional and phenotypic differences between CD4+ and CD4-T cell receptor-gamma delta clones from peripheral blood. | |
Muench et al. | Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver | |
Denning et al. | Human postnatal CD4-CD8-CD3-thymic T cell precursors differentiate in vitro into T cell receptor delta-bearing cells. | |
Vandekerckhove et al. | Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. | |
Knobloch et al. | Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency. | |
Michon et al. | Induction of natural killer effectors from human thymus with recombinant IL-2. | |
Moretta et al. | Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells. | |
Koide et al. | Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma, delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. | |
Cicuttini et al. | A novel population of natural killer progenitor cells isolated from human umbilical cord blood. | |
Sosman et al. | Specific recognition of human leukemic cells by allogeneic T cell lines | |
JP2006122054A (en) | Population of cells enriched for myeloid and/or lymphoid progenitors, and methods of making and using | |
Aparicio et al. | Isolation and characterization of (gamma, delta) CD4+ T cell clones derived from human fetal liver cells. | |
Barcena et al. | A role for interleukin 4 in the differentiation of mature T cell receptor gamma/delta+ cells from human intrathymic T cell precursors. | |
Haagen et al. | The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2 | |
Richards et al. | Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression | |
Kusunoki et al. | Evidence for in vivo clonal proliferation of unique population of blood CD4-/CD8-T cells bearing T-cell receptor alpha and beta chains in two normal men | |
Van de Griend et al. | In vitro expansion and analysis of cloned cytotoxic T cells derived from patients with chronic T gamma lymphoproliferative disorders |